These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies. Hattori T, McGeer PL, Fibiger HC, McGeer EG. Brain Res; 1973 May 17; 54():103-14. PubMed ID: 4350810 [No Abstract] [Full Text] [Related]
5. Modulation of neostriatal acetylcholine in the rat by dopamine and 5-hydroxytryptamine afferents. Butcher SH, Butcher LL, Cho AK. Life Sci; 1976 Apr 01; 18(7):733-43. PubMed ID: 1263754 [No Abstract] [Full Text] [Related]
6. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Quirion R, Chiueh CC, Everist HD, Pert A. Brain Res; 1985 Feb 18; 327(1-2):385-9. PubMed ID: 2985182 [Abstract] [Full Text] [Related]
8. Substance P: localization within paleostriatal-tegmental pathways in the pigeon. Reiner A, Karten HJ, Solina AR. Neuroscience; 1983 May 18; 9(1):61-85. PubMed ID: 6192356 [No Abstract] [Full Text] [Related]
9. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Agid Y, Javoy F, Glowinski J. Nat New Biol; 1973 Oct 03; 245(144):150-1. PubMed ID: 4517903 [No Abstract] [Full Text] [Related]
10. Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus. Javoy F, Hamon M, Glowinski J. Eur J Pharmacol; 1970 May 03; 10(2):178-88. PubMed ID: 4393431 [No Abstract] [Full Text] [Related]
13. [Tremor and motility following oxotremorine and harmine in rats with lesions of the nigro-striatal system]. Westermann KH, Oelszner W, Staib AH, Funk K. Acta Biol Med Ger; 1974 May 03; 33(1):67-76. PubMed ID: 4153886 [No Abstract] [Full Text] [Related]
15. Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment. Pericić D, Walters JR. J Pharm Pharmacol; 1976 Jun 03; 28(6):527-30. PubMed ID: 7658 [No Abstract] [Full Text] [Related]
19. Analysis of the fine structure of the dopaminergic nigrostriatal projection by electron microscopic autoradiography. Hattori T, Fibiger HC, McGeer PL, Maler L. Exp Neurol; 1973 Dec 03; 41(3):599-611. PubMed ID: 4128166 [No Abstract] [Full Text] [Related]